About this Journal Submit a Manuscript Table of Contents
Journal of Allergy
Volume 2012 (2012), Article ID 273752, 8 pages
http://dx.doi.org/10.1155/2012/273752
Review Article

Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease

1Department of Immunogenetics and Allergy, Instituto Nacional de Enfermedades Respiratorias, 14080 DF, Mexico
2Otolaryngology Department, Instituto Nacional de Enfermedades Respiratorias, 14080 DF, Mexico

Received 15 February 2012; Accepted 11 May 2012

Academic Editor: A. P. Sampson

Copyright © 2012 Maria L. Garcia Cruz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. P. Berges-Gimeno, R. A. Simon, and D. D. Stevenson, “The natural history and clinical characteristics of aspirin-exacerbated respiratory disease,” Annals of Allergy, Asthma and Immunology, vol. 89, no. 5, pp. 474–478, 2002. View at Scopus
  2. A. Szczeklik and D. D. Stevenson, “Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management,” Journal of Allergy and Clinical Immunology, vol. 111, no. 5, pp. 913–921, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. A. Joe and K. Thakkar, “Chronic Rhinosinusitis and Asthma,” Otolaryngologic Clinics of North America, vol. 41, no. 2, pp. 297–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Malekzadeh, M. Hamburger, J. F. Biedlingmaier, A. Trifillis, and J. N. Baraniuk, “Epithelial and glandular metaplasia in the middle turbinates of chronic sinusitis patients correlate with CT scan severity,” Journal of Allergy and Clinical Immunology, vol. 101, p. S250, 1998.
  5. S. Malekzadeh and J. F. McGuire, “The new histologic classification of chronic rhinosinusitis,” Current Allergy and Asthma Reports, vol. 3, no. 3, pp. 221–226, 2003. View at Scopus
  6. S. C. Payne, S. B. Early, P. Huyett, J. K. Han, L. Borish, and J. W. Steinke, “Evidence for distinct histologic profile of nasal polyps with and without eosinophilia,” Laryngoscope, vol. 121, no. 10, pp. 2262–2267, 2011. View at Publisher · View at Google Scholar
  7. J. Adamjee, H. J. Suh, H. S. Park et al., “Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma,” Journal of Pathology, vol. 209, no. 3, pp. 392–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Cowburn, K. Sladek, J. Soja et al., “Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma,” Journal of Clinical Investigation, vol. 101, no. 4, pp. 834–846, 1998. View at Scopus
  9. T. Saitoh, T. Kusunoki, T. Yao et al., “Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis,” Rhinology, vol. 47, no. 3, pp. 275–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Fuentes-Beltrán, R. Montes-Vizuet, E. Valencia-Maqueda, M. C. Negrete-García, M. D. L. García-Cruz, and L. M. Teran, “Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients,” Clinical and Experimental Allergy, vol. 39, no. 4, pp. 491–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Szczeklik, E. Nizankowska, and M. Duplaga, “Natural history of aspirin-induced asthma,” European Respiratory Journal, vol. 16, no. 3, pp. 432–436, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Hedman, J. Kaprio, T. Poussa, and M. M. Nieminen, “Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study,” International Journal of Epidemiology, vol. 28, no. 4, pp. 717–722, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Kasper, K. Sladek, M. Duplaga et al., “Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland,” Allergy, vol. 58, no. 10, pp. 1064–1066, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Jenkins, J. Costello, and L. Hodge, “Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice,” British Medical Journal, vol. 328, no. 7437, pp. 434–437, 2004. View at Scopus
  15. J. R. McDonald, D. A. Mathison, and D. D. Stevenson, “Aspirin intolerance in asthma. Detection by oral challenge,” The Journal of Allergy and Clinical Immunology, vol. 50, no. 4, pp. 198–207, 1972. View at Scopus
  16. A. Szczeklik, E. Nizankowska, and M. Duplaga, “Natural history of aspirin-induced asthma,” European Respiratory Journal, vol. 16, no. 3, pp. 432–436, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Sánchez-Borges and A. Capriles-Hulett, “Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity,” Annals of Allergy, Asthma and Immunology, vol. 84, no. 1, pp. 101–106, 2000. View at Scopus
  18. M. Kupczyk, I. Kupryś, P. Górski, and P. Kuna, “Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma,” Annals of Allergy, Asthma and Immunology, vol. 92, no. 4, pp. 453–458, 2004. View at Scopus
  19. C. A. Pérez-Novo, J. B. Watelet, C. Claeys, P. Van Cauwenberge, and C. Bachert, “Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis,” Journal of Allergy and Clinical Immunology, vol. 115, no. 6, pp. 1189–1196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. L. Kowalski, R. Pawliczak, J. Wozniak et al., “Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 2 I, pp. 391–398, 2000. View at Scopus
  21. L. Mastalerz, M. Sanak, J. Kumik, et al., “Exhaled eicosanoids following bronchial aspirin challenge in asthma patients with and without aspirin hypersensitivity: the pilot study,” Journal of Allergy, vol. 2012, Article ID 696792, 11 pages, 2012. View at Publisher · View at Google Scholar
  22. D. Lezcano-Meza, B. Dávila-Dávila, A. Vega-Miranda, M. C. Negrete-García, and L. M. Teran, “Interleukin (IL)-4 and to a lesser extent either IL-13 or interferon-gamma regulate the production of eotaxin-2/CCL24 in nasal polyps,” Allergy, vol. 58, no. 10, pp. 1011–1017, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Pods, D. Ross, S. Van Hülst, C. Rudack, and S. Maune, “RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad,” Allergy, vol. 58, no. 11, pp. 1165–1170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. L. M. Terán, Y. Ledesma-Soto, S. Krengel, and D. Lezcano-Meza, “Eotaxins in bronchial asthma and nasal polyps,” Gaceta Medica de Mexico, vol. 142, no. 2, pp. 139–144, 2006. View at Scopus
  25. L. M. Teran, H. S. Park, R. Djukanovic, K. Roberts, and S. Holgate, “Cultured nasal polyps from nonatopic and atopic patients release RANTES spontaneously and after stimulation with phytohemagglutinin,” Journal of Allergy and Clinical Immunology, vol. 100, no. 4, pp. 499–504, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. J. E. Meyer, I. Berner, L. M. Teran et al., “RANTES production by cytokine-stimulated nasal fibroblasts: its inhibition by glucocorticoids,” International Archives of Allergy and Immunology, vol. 117, no. 1, pp. 60–67, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Jankowski, D. A. Moneret-Vautrin, R. Goetz, and M. Wayoff, “Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma,” Rhinology, vol. 30, no. 4, pp. 249–258, 1992. View at Scopus
  28. C. Bachert, N. Zhang, J. Patou, T. Van Zele, and P. Gevaert, “Role of staphylococcal superantigens in upper airway disease,” Current Opinion in Allergy and Clinical Immunology, vol. 8, no. 1, pp. 34–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. J. Suh, S. H. Yoon, A. P. Sampson et al., “Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma,” Clinical and Experimental Allergy, vol. 34, no. 8, pp. 1270–1275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Sekigawa, A. Tajima, T. Hasegawa et al., “Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma,” Clinical and Experimental Allergy, vol. 39, no. 7, pp. 972–981, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. K. M. Stankovic, H. Goldsztein, D. D. Reh, M. P. Platt, and R. Metson, “Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma,” Laryngoscope, vol. 118, no. 5, pp. 881–889, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. K. A. Zander, M. T. Saavedra, J. West, V. Scapa, L. Sanders, and T. T. Kingdom, “Protein microarray analysis of nasal polyps from aspirin-sensitive and aspirin-tolerant patients with chronic rhinosinusitis,” American Journal of Rhinology and Allergy, vol. 23, no. 3, pp. 268–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. W. Dekker, E. Nizankowska, M. Schmitz-Schumann et al., “Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes,” Clinical and Experimental Allergy, vol. 27, no. 5, pp. 574–577, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Szczeklik, “Aspirin-induced asthma as a viral disease,” Clinical Allergy, vol. 18, no. 1, pp. 15–20, 1988. View at Scopus
  35. D. D. Stevenson and A. Szczeklik, “Clinical and pathologic perspectives on aspirin sensitivity and asthma,” Journal of Allergy and Clinical Immunology, vol. 118, no. 4, pp. 773–786, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. F. Mullarkey, J. S. Hill, and D. R. Webb, “Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia,” Journal of Allergy and Clinical Immunology, vol. 65, no. 2, pp. 122–126, 1980. View at Scopus
  37. R. L. Jacobs, P. M. Freedman, and R. N. Boswell, “Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation,” Journal of Allergy and Clinical Immunology, vol. 67, no. 4, pp. 253–262, 1981. View at Scopus
  38. D. A. Moneret-Vautrin, R. Jankowski, M. C. Bene et al., “NARES: a model of inflammation caused by activated eosinophils?” Rhinology, vol. 30, no. 3, pp. 161–168, 1992. View at Scopus
  39. R. U. Lee and D. D. Stevenson, “Aspirin-exacerbated respiratory disease: evaluation and management,” Allergy, Asthma and Immunology Research, vol. 3, no. 1, pp. 3–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Muñoz-del-Castillo, A. Jurado-Ramos, R. Soler et al., “Allergic profile of nasal polyposis,” Journal of Investigational Allergology and Clinical Immunology, vol. 19, pp. 110–116, 2009. View at Scopus
  41. T. Van Zele, P. Gevaert, G. Holtappels et al., “Oral steroids and doxycycline: two different approaches to treat nasal polyps,” Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1069–1076, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Vaidyanathan, M. Barnes, P. Williamson, P. Hopkinson, P. T. Donnan, and B. Lipworth, “Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial,” Annals of Internal Medicine, vol. 154, no. 5, pp. 293–302, 2011. View at Scopus
  43. J. Mullol and I. Alobid, “Combined oral and intranasal corticosteroid therapy: an advance in the management of nasal Polyposis?” Annals of Internal Medicine, vol. 154, no. 5, pp. 365–367, 2011. View at Scopus
  44. F. Mori, S. Barni, N. Pucci, M. E. Rossi, C. Orsi Battaglini, and E. Novembre, “Upper airways disease: role of corticosteroids,” International journal of immunopathology and pharmacology, vol. 23, no. 1, pp. 61–66, 2010. View at Scopus
  45. J. M. Rowe-Jones, M. Medcalf, S. R. Durham, D. H. Richards, and I. S. Mackay, “Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray,” Rhinology, vol. 43, no. 1, pp. 2–10, 2005. View at Scopus
  46. T. Kamani and A. Sama, “Management of nasal polyps in “Aspirin sensitive asthma” triad,” Current Opinion in Otolaryngology and Head and Neck Surgery, vol. 19, no. 1, pp. 6–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Ichimura, Y. I. Shimazaki, T. Ishibashi, and R. Higo, “Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis,” Auris Nasus Larynx, vol. 23, pp. 48–56, 1996. View at Scopus
  48. D. A. Kieff and N. Y. Busaba, “Efficacy of montelukast in the treatment of nasal polyposis,” Annals of Otology, Rhinology and Laryngology, vol. 114, no. 12, pp. 941–945, 2005. View at Scopus
  49. D. D. Stevenson, M. A. Hankammer, D. A. Mathison, S. C. Christiansen, and R. A. Simon, “Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes,” Journal of Allergy and Clinical Immunology, vol. 98, no. 4, pp. 751–758, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. M. P. Berges-Gimeno, R. A. Simon, and D. D. Stevenson, “Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease,” Annals of Allergy, Asthma and Immunology, vol. 90, no. 3, pp. 338–341, 2003. View at Scopus
  51. J. W. Steinke, S. C. Payne, and L. Borish, “Interleukin-4 in the generation of the AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization,” Journal of Allergy, vol. 2012, Article ID 182090, 9 pages, 2012. View at Publisher · View at Google Scholar
  52. J. M. Sweet, D. D. Stevenson, R. A. Simon, and D. A. Mathison, “Long-term effects of aspirin desensitization—treatment for aspirin-sensitive rhinosinusitis-asthma,” Journal of Allergy and Clinical Immunology, vol. 85, no. 1, pp. 59–65, 1990. View at Scopus
  53. O. G. Awad, M. B. Fasano, J. H. Lee, and S. M. Graham, “Asthma outcomes after endoscopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients,” American Journal of Rhinology, vol. 22, no. 2, pp. 197–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Marchioni, M. Alicandri-Ciufelli, F. Mattioli et al., “Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis,” Acta Oto-Laryngologica, vol. 128, no. 9, pp. 1019–1026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Hopkins, R. Slack, V. Lund, P. Brown, L. Copley, and J. Browne, “Long-term outcomes from the english national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis,” Laryngoscope, vol. 119, no. 12, pp. 2459–2465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Jankowski, D. Pigret, and F. Decroocq, “Comparison of functional results after ethmoidectomy and nasalization for diffuse and severe nasal polyposis,” Acta Oto-Laryngologica, vol. 117, no. 4, pp. 601–608, 1997. View at Scopus
  57. R. Jankowski and C. Bodino, “Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalisation),” Rhinology, vol. 41, no. 4, pp. 220–230, 2003. View at Scopus
  58. R. Jankowski and C. Bodino, “Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalisation of the ethmoid—radical ethmoidectomy is functional surgery for NPS,” Rhinology, vol. 41, no. 4, pp. 211–219, 2003. View at Scopus
  59. R. Jankowski, “Nasalisation: technique chirurgicale,” Journal Français d'Oto-Rhino-Laryngologie, vol. 3, pp. 221–225, 1995.
  60. S. Buyukozturk, A. Gelincik, I. Aslan, S. Aydin, B. Colakoglu, and M. Dal, “Methotrexate: can it be a choice for nasal polyposis in aspirin exacerbated respiratory disease,” Journal of Asthma, vol. 46, no. 10, pp. 1037–1041, 2009. View at Publisher · View at Google Scholar · View at Scopus